A PHASE II III RANDOMIZED STUDY COMPARING EFFICACY OF NOLATREXED (THYMITAQ, AG337) TO DOXORUBICIN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)/

Citation
T. Mok et al., A PHASE II III RANDOMIZED STUDY COMPARING EFFICACY OF NOLATREXED (THYMITAQ, AG337) TO DOXORUBICIN IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA (HCC)/, Annals of oncology, 9, 1998, pp. 664-664
Citations number
NO
Categorie Soggetti
Oncology
Journal title
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
664 - 664
Database
ISI
SICI code
0923-7534(1998)9:<664:APIIRS>2.0.ZU;2-9